Myomo (NYSEAMERICAN:MYO) Director Purchases $27,026.63 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Joseph Jr. Manko acquired 30,367 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was acquired at an average cost of $0.89 per share, for a total transaction of $27,026.63. Following the acquisition, the director owned 2,309,775 shares of the company’s stock, valued at $2,055,699.75. The trade was a 1.33% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Myomo Stock Performance

Shares of MYO traded down $0.07 on Monday, reaching $0.84. The company’s stock had a trading volume of 429,115 shares, compared to its average volume of 419,367. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36. The stock has a market capitalization of $32.42 million, a P/E ratio of -2.33 and a beta of 1.39. The stock’s 50 day simple moving average is $0.76 and its two-hundred day simple moving average is $0.85. Myomo, Inc. has a 12-month low of $0.61 and a 12-month high of $3.45.

Institutional Investors Weigh In On Myomo

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rosalind Advisors Inc. raised its stake in Myomo by 1.3% during the 4th quarter. Rosalind Advisors Inc. now owns 3,839,772 shares of the company’s stock worth $3,494,000 after acquiring an additional 48,984 shares during the period. Jefferies Financial Group Inc. bought a new stake in Myomo during the 4th quarter worth approximately $641,000. Geode Capital Management LLC raised its stake in Myomo by 160.8% during the 2nd quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after acquiring an additional 412,631 shares during the period. AQR Capital Management LLC raised its stake in Myomo by 47.8% during the 4th quarter. AQR Capital Management LLC now owns 434,376 shares of the company’s stock worth $395,000 after acquiring an additional 140,427 shares during the period. Finally, State Street Corp raised its stake in Myomo by 5.1% during the 4th quarter. State Street Corp now owns 399,853 shares of the company’s stock worth $364,000 after acquiring an additional 19,563 shares during the period. Institutional investors own 44.99% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum reissued a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $7.67.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.